DIAGNOS Inc.
DGNOF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.45 | -0.44 | -0.36 | 0.19 |
| FCF Yield | -14.16% | -10.96% | -7.80% | -7.94% |
| EV / EBITDA | -8.07 | -9.26 | -12.60 | -7.24 |
| Quality | ||||
| ROIC | -115.32% | -1,937.37% | -759.23% | -145.31% |
| Gross Margin | -909.04% | -492.45% | -95.32% | -130.13% |
| Cash Conversion Ratio | 0.85 | 0.69 | 0.76 | 0.66 |
| Growth | ||||
| Revenue 3-Year CAGR | -38.16% | -13.95% | 9.80% | -6.47% |
| Free Cash Flow Growth | -69.17% | -13.12% | -36.39% | 47.32% |
| Safety | ||||
| Net Debt / EBITDA | -0.84 | -1.21 | -0.96 | -0.05 |
| Interest Coverage | -6.42 | -4.71 | -9.16 | -37.54 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 41.82 | 18.74 |
| Cash Conversion Cycle | 475.77 | 197.47 | -72.26 | 298.97 |